Risk Factors of Invasive Pulmonary Aspergillosis after Living and Deceased Donor Liver Transplantation and Lessons from Successfully Treated Cases

Exploratory study of therapeutic strategies for invasive pulmonary aspergillosis after liver transplantation - Treatment strategies for invasive pulmonary aspergillosis after liver transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041949

Enrollment

500

Registered

2020-09-30

Start date

2020-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver transplantation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have undergone living- or deceased-donor liver transplants in our hospital

Exclusion criteria

Exclusion criteria: Patients who could not undergo a liver transplant

Design outcomes

Primary

Measure	Time frame
Life-saving rates of invasive pulmonary aspergillosis after liver transplantation	—

Countries

Japan

Contacts

Public ContactKodai Abe

Keio University School of Medicine Department of Surgery

08medrfcab@keio.jp03-5363-3802

Outcome results